The Modern Financial Terminal

Subscribe for $2

Trusted by leading companies and financial institutions

Bayer Stock BAYN.DE

Currency:

Price

45.45 EUR

Today +/-

-3.11 EUR

Today %

-6.61 %

Ticker
BAYN.DE

ISIN
DE000BAY0017

Bayer stock price

Weekly

Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Bayer stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Bayer stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Bayer stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Bayer's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Bayer Stock Price History

Date	Bayer Price
2/18/2026	45.45 EUR
2/17/2026	48.56 EUR
2/16/2026	45.94 EUR
2/13/2026	45.99 EUR
2/12/2026	45.69 EUR
2/11/2026	46.13 EUR
2/10/2026	46.17 EUR
2/9/2026	46.28 EUR
2/6/2026	45.80 EUR
2/5/2026	44.82 EUR
2/4/2026	45.15 EUR
2/3/2026	45.27 EUR
2/2/2026	45.01 EUR
1/30/2026	44.56 EUR
1/29/2026	44.02 EUR
1/28/2026	45.19 EUR
1/27/2026	46.74 EUR
1/26/2026	46.37 EUR
1/23/2026	44.56 EUR
1/22/2026	44.17 EUR
1/21/2026	42.69 EUR
1/20/2026	42.92 EUR

Bayer Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Revenue

EBIT

Net Income

Details

Bayer Income Statement, Balance Sheet, Cash Flow Statement

REVENUE (B EUR)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B EUR)

NET INCOME (B EUR)

NET INCOME GROWTH (%)

DIVIDEND (EUR)DIV. (EUR)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

DOCUMENTS

1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e	2028e	2029e	2030e	2031e
20.97	22.2	22.79	24.85	28.12	28.06	25.19	29.99	28.94	28.96	28.57	29.76	27.38	28.96	32.39	32.92	31.17	35.09	36.53	39.76	40.16	41.34	46.09	34.94	35.02	36.74	43.55	41.4	44.08	50.74	47.64	46.61	46.53	46.76	47.83	50.06	51.25	51.32	50.2
–	5.88	2.67	9.04	13.16	-0.22	-10.22	19.02	-3.49	0.07	-1.35	4.17	-7.98	5.74	11.84	1.65	-5.32	12.58	4.10	8.85	1.00	2.94	11.48	-24.18	0.21	4.93	18.52	-4.93	6.48	15.10	-6.11	-2.16	-0.17	0.50	2.29	4.65	2.40	0.12	-2.17
42.04	43.28	42.55	42.29	42.93	44.85	46.08	46.81	42.84	39.54	41.07	41.59	45.12	47.25	49.51	50.01	51.44	51.26	50.79	52.06	51.82	51.84	54.35	66.36	67.49	58.14	59.55	53.77	61.85	60.84	58.54	54.36	54.46	54.19	52.97	50.62	49.43	49.37	50.47
8.82	9.61	9.7	10.51	12.07	12.59	11.61	14.04	12.4	11.45	11.73	12.38	12.36	13.68	16.03	16.46	16.03	17.99	18.55	20.7	20.81	21.43	25.05	23.19	23.63	21.36	25.93	22.26	27.27	30.87	27.89	25.34	0	0	0	0	0	0	0
0.68	1.01	1.22	1.39	1.5	1.61	2	1.82	0.97	1.06	-1.36	0.6	1.6	1.68	4.71	1.72	1.36	1.3	2.47	2.45	3.19	3.43	4.11	4.53	7.34	1.7	4.09	-10.5	1	4.15	-2.94	-2.55	4.71	4.8	5.23	5.8	6.13	6.28	0
–	48.53	21.55	13.81	7.97	7.31	24.04	-9.29	-46.86	9.84	-228.40	-144.31	164.84	5.39	179.92	-63.51	-20.94	-4.27	89.85	-0.97	30.38	7.43	19.96	10.24	61.91	-76.89	141.36	-356.54	-109.53	315.00	-170.87	-13.23	-284.64	1.85	8.92	10.96	5.71	2.35	–
-	-	-	-	-	-	-	-	-	-	-	-	0.55	0.95	1.00	1.35	1.40	1.38	1.48	1.62	1.87	2.07	2.21	2.46	2.66	2.76	2.80	2.80	2.00	2.00	2.40	0.11	0.11	5.02	5.46	5.79	6.31	6.43	-
–	–	–	–	–	–	–	–	–	–	–	–	–	72.73	5.26	35.00	3.70	-1.43	7.25	9.46	15.43	10.70	6.76	11.31	8.13	3.76	1.45	–	-28.57	–	20.00	-95.42	–	4,463.64	8.76	6.04	8.98	1.90	–
381	393	736	727	742	742	742	742	742	742	742	742	742	805	837	838	839	840	840	840	840	840.31	840.31	845.95	885.19	940.76	981.69	982.42	982.42	982.42	982.42	982.42	0	0	0	0	0	0	0
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Keystats

ⓘ

Revenue and Growth

The Bayer Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Bayer is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

ASSETS

CASH BALANCE (B EUR)

RECEIVABLES (B EUR)

OTHER RECEIVABLES (B EUR)OTHER REC. (B EUR)

INVENTORIES (B EUR)

OTHER CURRENT ASSETS (B EUR)OTHER CURRENT LIAB. (B EUR)

CURRENT ASSETS (B EUR)

TANGIBLE ASSETS (B EUR)

LONG-TERM INVESTMENTS (B EUR)LONG-T. INVEST. (B EUR)

LONG-TERM RECEIVABLES (B EUR)LONG-T. REC. (B EUR)

INTANGIBLE ASSETS (B EUR)INTANGIBLE ASSETS (B EUR)

GOODWILL (B EUR)

OTHER NON-CURRENT ASSETS (B EUR)OTHER NON-CURRENT ASSETS (B EUR)

NON-CURRENT ASSETS (B EUR)

TOTAL ASSETS (B EUR)

LIABILITIES

COMMON STOCK (B EUR)

ADDITIONAL PAID-IN CAPITAL (B EUR)

RETAINED EARNINGS (B EUR)

OTHER EQUITY (B EUR)OTHER EQUITY (B EUR)

UNREALIZED GAINS/LOSSES (M EUR)UNREAL. GAINS/LOSSES (M EUR)

EQUITY (B EUR)

LIABILITIES (B EUR)

PROVISIONS (B EUR)

OTHER SHORT-TERM LIABILITIES (B EUR)OTHER SHORT-TERM LIAB. (B EUR)

SHORT-TERM DEBTS (B EUR)SHORT-TERM DEBTS (B EUR)

SHORT-TERM PORTION OF LONG-TERM DEBTS (B EUR)LONG-TERM DEBT PORTION (B EUR)

SHORT-TERM RECEIVABLES (B EUR)SHORT-TERM REC. (B EUR)

LONG-TERM LIABILITIES (B EUR)LONG-T. LIAB. (B EUR)

DEFERRED TAXES (B EUR)

OTHER LIABILITIES (B EUR)OTHER LIAB. (B EUR)

LONG-TERM LIABILITIES (B EUR)LONG-T. LIABILITIES (B EUR)

DEBT (B EUR)

TOTAL CAPITAL (B EUR)

1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

2.68	2.96	2.66	2.42	2.46	1.72	3.14	0.7	0.77	0.8	2.86	3.6	3.74	3.32	2.87	2.3	2.85	3.55	4.29	2.12	1.8	2.06	2.13	5.42	9.1	5	5.4	11.88	7.74	10.15	10.59	8.09
4.32	4.4	4.35	4.92	5.46	5.57	5.33	6.24	5.42	5.54	5.07	5.58	5.2	5.8	5.83	5.95	6.11	6.67	7.06	7.43	7.57	9.1	9.93	10.97	8.58	11.71	11.68	9.55	10.05	10.31	9.34	8.97
0.89	1.11	1.19	1.49	1.44	1.66	1.58	2.41	2.45	4.21	3.85	4.15	2.15	1.8	1.67	1.79	1.7	1.5	1.79	1.85	1.72	1.29	1.46	3.77	2.45	2.42	3.17	2.61	2.93	3.14	3.18	3.22
4.18	4.26	4.76	5.14	5.42	5.78	4.99	6.1	5.82	6.34	5.89	6.22	5.5	6.15	6.22	6.68	6.09	6.1	6.37	6.98	7.13	8.48	8.55	8.41	6.55	11.13	10.65	10.96	11.31	13.64	13.95	13.47
0	0.21	0.09	0	0	0	0	0	0	0	0	0	0	2.93	0.08	0.44	0.24	0.5	0.56	0.61	0.81	0.63	1.75	1.88	3.39	0.79	1.53	0.67	0.55	0.82	0.8	0.7
12.07	12.93	13.04	13.97	14.78	14.74	15.04	15.46	14.45	16.89	17.67	19.55	16.59	19.99	16.67	17.16	16.99	18.32	20.07	18.99	19.03	21.55	23.82	30.45	30.07	31.07	32.44	35.68	32.58	38.06	37.85	34.44
7.51	7.55	7.97	8.98	10.31	10.83	11.99	13.35	13.54	12.44	9.94	9.18	8.32	8.87	8.82	9.49	9.41	9.84	9.82	9.86	10.02	11.43	12.38	13.11	7.63	12.94	12.48	11.72	12.69	13.67	13.32	13.46
0.59	0.63	0.98	0.99	0.87	1.1	1.42	2.16	3.15	2.2	1.78	1.65	2.22	1.63	1.61	1.36	1.22	1.28	1.4	1.36	0.46	1.19	1.22	1.75	5.27	1.59	0.97	0.99	1.2	1.49	1.34	1.35
0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.17	0.67	0.46	0.55	0.53	0.46	0.55	1.22	0.32	0.33	0.41	0.48	1.5	1.5	1.51	2.01	1.9	2.19	1.95
0.16	0.39	0.45	0.46	0.54	0.7	1.51	3.87	4.04	6.02	4.58	4.14	5.07	15.81	14.56	13.95	12.84	11.16	10.3	9.46	8.91	15.65	15.18	13.57	11.67	36.7	34.71	25.42	26.26	24.18	23.36	22.11
0	0	0.03	0.27	0.51	1.21	0.71	0.98	0.98	2.86	1.94	1.88	2.62	8.23	8.22	8.65	8.7	9	9.16	9.29	9.86	15.35	16.1	16.31	14.75	38.44	39.13	36.42	40.11	39.65	32.3	30.02
0.22	0.17	0.17	0.62	0.68	0.68	0.62	0.65	0.89	1.29	1.54	1.4	1.7	1.21	0.85	1.44	1.33	1.38	1.56	1.82	1.82	4.08	4.89	6.64	5.21	4.5	4.95	5.07	5.41	6.22	6.19	7.52
8.47	8.74	9.61	11.31	12.91	14.52	16.24	20.99	22.59	24.8	19.77	18.26	20.13	35.9	34.71	35.35	34.05	33.19	32.7	32.35	32.29	48.01	50.1	51.79	45.01	95.67	93.74	81.13	87.66	87.12	78.7	76.41
20.54	21.66	22.65	25.28	27.7	29.25	31.28	36.45	37.04	41.69	37.45	37.8	36.72	55.89	51.38	52.51	51.04	51.51	52.77	51.34	51.32	69.56	73.92	82.24	75.09	126.73	126.17	116.8	120.24	125.17	116.56	110.85

1.72	1.77	1.8	1.85	1.87	1.87	1.87	1.87	1.87	1.87	1.87	1.87	1.87	1.96	1.96	1.96	2.12	2.12	2.12	2.12	2.12	2.12	2.12	2.12	2.12	2.39	2.52	2.52	2.52	2.52	2.52	2.52
2.39	2.51	2.59	2.86	2.95	2.95	2.94	2.94	2.94	2.94	2.94	2.94	2.94	4.03	4.03	4.03	6.17	6.17	6.17	6.17	6.17	6.17	6.17	9.66	9.66	18.39	18.26	18.26	18.26	18.26	18.26	18.26
5.32	5.16	5.94	6.8	7.78	8.73	9.97	10.86	10.81	11.14	9.12	9.36	6.94	8.22	12.95	13.01	10.61	10.55	10.93	10.19	12.43	11.82	15.98	18.56	25.03	25.74	26.15	13.06	13.35	17.23	12.18	9.87
-0.34	-0.95	-1.22	-0.98	-0.58	-0.98	0.23	0.47	1.3	-0.61	-1.72	-1.97	-0.74	-1.5	-2.29	-2.8	0	0	0	0	0	0	0	0	0	-0.66	0.02	-3.43	-1.31	0.65	-0.11	1.25
0	0	0	0	0	0	0	0	0	0	0	66	62	58	86	68	0	0	0	0	0	0	0	0	0	122	310	117	212	112	81	16
9.09	8.49	9.11	10.53	12.01	12.57	15.01	16.14	16.92	15.34	12.21	12.27	11.08	12.77	16.73	16.26	18.9	18.83	19.21	18.47	20.72	20.11	24.27	30.33	36.8	45.98	47.25	30.52	33.02	38.77	32.93	31.91
1.07	1.23	1.24	1.33	1.6	1.61	1.56	2.02	1.99	2.53	2.27	2.28	1.97	2.37	2.47	2.46	2.74	3.5	3.78	4.3	4.47	5.36	5.95	6.41	5.13	6.04	6.43	5.68	6.79	7.55	7.46	7.52
0.44	0.49	0.46	0.47	0.48	0.53	0.6	0.58	0.59	0.81	0.73	0.69	0	0	0	0.85	0.84	0.78	0.82	0.78	0.78	0.78	0.98	1.08	0.16	0.37	0.34	0.37	0.34	0.43	0.35	0.98
1.01	1.88	1.93	2.17	1.37	1.41	2.64	4.18	3.85	3.78	4.6	5.09	5.92	8.67	7.04	4.71	4.18	5.1	5.56	5.82	6.61	7.75	7.58	8.15	7.25	13.76	14.47	22.36	19.22	19.57	16.94	15.25
0.07	0.05	0.04	0.05	0.85	0.93	0.33	1.83	1.47	1.18	0.93	1	0.18	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.21	1.08	1.04	1.13	0.85	1.34	1.69	1.25	1.71	1.47	0.86	0.84	1	4.48	1.11	5.81	1.23	1.46	3.24	2.21	2.16	1.44	2.47	2.89	1.05	2.96	1.98	8.36	3.05	7.54	4.7	5.21
3.79	4.73	4.69	5.15	5.15	5.83	6.81	9.85	9.61	9.77	9.39	9.89	9.07	15.52	10.61	13.84	8.97	10.84	13.39	13.1	14.02	15.34	16.98	18.54	13.59	23.13	23.22	36.77	29.4	35.08	29.46	28.95
1.32	1.26	1.44	1.62	2.15	2.29	2.36	2.8	3.07	7.32	7.11	7.12	7.19	14.72	12.91	9.96	10.95	9.64	7.75	6.76	5.4	17.8	16.33	15.38	12.16	37.71	36.91	33.2	36.48	33.78	38.17	35.49
0	0	0	0.43	0.62	0.78	1.16	1.6	1.24	2.45	1.46	1.25	0.28	4.35	3.87	3.59	3.21	2.58	2.12	0.94	1.19	0.69	0.83	1.33	1.15	4.67	3.76	1.18	0.93	0.73	0.79	0.87
6.12	6.95	7.16	7.32	7.55	7.58	5.77	5.82	6.1	6.7	7.15	7.17	9.03	8.46	7.17	8.78	8.96	9.55	10.24	11.97	9.9	16.03	14.33	15.1	11.32	15.08	14.86	14.99	20.26	16.36	14.76	13.5
7.44	8.21	8.6	9.37	10.31	10.65	9.29	10.22	10.41	16.47	15.72	15.54	16.5	27.53	23.95	22.34	23.12	21.78	20.1	19.67	16.49	34.51	31.49	31.8	24.63	57.46	55.53	49.36	57.67	50.87	53.72	49.85
11.23	12.94	13.29	14.52	15.46	16.48	16.1	20.07	20.02	26.24	25.11	25.43	25.57	43.04	34.56	36.17	32.09	32.61	33.49	32.77	30.51	49.85	48.47	50.34	38.23	80.58	78.74	86.13	87.07	85.95	83.18	78.81
20.32	21.43	22.4	25.05	27.47	29.04	31.1	36.21	36.94	41.57	37.32	37.69	36.64	55.81	51.29	52.43	50.99	51.44	52.71	51.24	51.23	69.95	72.74	80.67	75.03	126.56	125.99	116.65	120.09	124.72	116.11	110.71

Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Bayer provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Bayer's financial health and stability.

Assets

Bayer's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Bayer must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Bayer after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Bayer's financial standing, aiding in investment evaluations and risk assessments.

NET INCOME (B EUR)

DEPRECIATION AND AMORTIZATION B EURDEPRECIATION (B EUR)

DEFERRED TAXES (M EUR)

CHANGES IN WORKING CAPITAL (B EUR)CHANGES IN WORKING CAPITAL (B EUR)

NON-CASH ITEM (B EUR)

PAID INTEREST (B EUR)

PAID TAXES (B EUR)

Net Cash Flow from Operating Activities (B EUR)NET CASH FLOW FROM OPERATING ACTIVITIES (B EUR)

CAPITAL EXPENDITURES (M EUR)

CASH FLOW FROM INVESTING ACTIVITIES (B EUR)CASH FLOW FROM INVESTING ACTIVITIES (B EUR)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (B EUR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B EUR)

INTEREST INCOME AND EXPENSES (M EUR)

NET DEBT CHANGE (B EUR)NET DEBT CHANGE (B EUR)

Net change in equity (B EUR)NET CHANGE IN EQUITY (B EUR)

CASH FLOW FROM FINANCING ACTIVITIES (B EUR)CASH FLOW FROM FINANCING ACTIVITIES (B EUR)

OTHER ITEMS OF FINANCING CASH FLOWS (EUR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (EUR)

TOTAL DIVIDENDS PAID (M EUR)

NET CHANGE IN CASH FLOW (B EUR)

FREE CASH FLOW (M EUR)

SHARE-BASED COMPENSATION (M EUR)

1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
1.2	1.66	2.1	2.31	2.78	3.15	3.36	3.29	1.61	1.57	-1.2	1.81	2.81	1.53	2.31	1.72	1.36	1.31	2.47	2.5	3.19	3.44	4.02	4.56	3.25	1.39	2.43	-15.56	1.02	4.17	-2.94
1.37	1.24	1.18	1.31	1.56	1.53	1.81	2.14	2.52	3.31	4.74	2.32	1.84	1.91	2.71	2.72	2.81	3.56	2.77	2.96	2.9	2.94	3.33	3.74	2.66	6.24	5.37	13.26	3.06	6.5	10.02
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.39	-0.28	-1.58	-1.43	-0.86	-1.42	-0.77	-1.95	0.3	1.07	-0.56	-1.29	-0.48	-0.29	-1.49	-1.86	0.59	0.52	-0.29	-0.88	-1.28	-1.24	-1.18	-0.87	-0.26	2.87	-0.51	6	0.26	-4.09	-3.86
0.4	0.29	0.29	0.14	0.02	-0.46	-1.27	-0.36	-0.53	-1.53	0.32	-0.39	-0.87	1.06	0.75	1.03	0.62	0.39	0.11	-0.05	0.37	0.67	0.72	1.66	2.49	-2.58	0.9	1.2	0.8	0.52	1.9
0.26	0.23	0.27	0.34	0.36	0.34	0.36	0.34	0.51	0.7	0.78	0.72	0.79	1.16	1.34	1.27	1.21	0.92	0.9	0.79	0.55	0.54	0.81	0.85	0.8	1.33	1.52	1.3	1.23	1.3	1.54
0	0	0	0	0	0	0	0	0	0	0	0	0	0.76	0.92	0.81	0.64	0.9	1.07	1.56	1.64	1.32	2.26	2.09	1.82	2.03	2.56	1.06	2.16	2.03	1.77
2.59	2.91	1.99	2.32	3.49	2.8	3.13	3.12	3.9	4.42	3.29	2.46	3.31	4.2	4.28	3.61	5.38	5.77	5.06	4.53	5.17	5.81	6.9	9.09	8.13	7.92	8.19	4.9	5.13	7.1	5.12
-1,613	-1,802	-1,620	-1,933	-2,359	-2,675	-2,632	-2,647	-2,617	-2,239	-1,653	-1,251	-1,389	-1,876	-1,860	-1,759	-1,575	-1,514	-1,615	-1,929	-2,157	-2,371	-2,517	-2,578	-2,366	-2,593	-2,650	-2,418	-2,611	-2,949	-2,751
-1.82	-3.21	-2.18	-1.38	-2.41	-3.18	0.21	-6.22	-2.13	-6.57	0.46	-0.81	-1.74	-14.73	3.19	-3.09	-1.13	-2.41	-3.89	-0.82	-2.58	-15.54	-2.76	-8.73	-0.43	-34.15	-0.67	-4.07	0.86	-2.38	-3.52
-0.21	-1.41	-0.56	0.56	-0.05	-0.51	2.85	-3.58	0.49	-4.33	2.11	0.44	-0.35	-12.85	5.05	-1.33	0.45	-0.9	-2.28	1.11	-0.42	-13.17	-0.25	-6.15	1.93	-31.56	1.98	-1.66	3.47	0.57	-0.77
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.04	0.52	0.15	0.05	-0.05	0.87	-0.61	2.06	-0.04	3.54	-0.32	0.51	-0.65	10.72	-5.61	1.53	-1.44	-1.54	-0.4	-1.95	-0.62	11.84	-2.93	-0.73	-2.48	17.82	-4.3	4.47	-2.45	-0.97	3.25
0.1	0.18	0.11	0.33	0.12	0	0.01	0	0	0	0	0.01	0	1.17	0	0	0	0	0	0	0	0	1.49	3.3	3.72	8.99	0	0	0	-0.01	-0
-0.49	0.09	-0.47	-0.5	-0.92	-0.18	-1.73	0.77	-1.55	2.21	-1.76	-0.76	-1.88	10.2	-7.73	-0.87	-3.62	-3.23	-2.21	-3.78	-2.54	9.74	-3.97	-0.35	-1.88	23.43	-8.39	0.42	-5.65	-4.22	-0.68
-262.00	-226.00	-271.00	-335.00	-357.00	-344.00	-360.00	-336.00	-484.00	-666.00	-782.00	-724.00	-787.00	-1,155.00	-1,344.00	-1,272.00	-1,206.00	-526.00	-574.00	-471.00	-342.00	-363.00	-666.00	-794.00	-755.00	-966.00	-1,478.00	-1,276.00	-1,200.00	-1,251.00	-1,552.00
-369	-382	-463	-543	-634	-712	-770	-953	-1,028	-662	-664	-559	-440	-535	-773	-1,126	-973	-1,160	-1,242	-1,366	-1,574	-1,739	-1,869	-2,126	-2,364	-2,407	-2,615	-2,768	-1,993	-1,985	-2,379
0.28	-0.22	-0.33	0.44	0.19	-0.56	1.63	-2.32	0.23	0.05	1.97	0.84	-0.28	-0.38	-0.38	-0.44	0.63	0.12	-1.07	-0.08	-0.04	0.19	0.01	0.04	5.68	-3.38	-0.87	1.01	0.37	0.61	0.74
973.5	1,103.4	365	390.6	1,132.5	126.8	497	476	1,284	2,185	1,641	1,205	1,917	2,325	2,419	1,852	3,803	4,259	3,445	2,603	3,014	3,439	4,378	6,514	5,768	5,325	5,537	2,478	2,517	4,147	2,366
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Bayer stock margins

The Bayer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bayer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bayer.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Gross margin

EBIT margin

Profit margin

Details

Bayer Stock Sales Revenue, EBIT, Earnings per Share

The Bayer earnings per share therefore indicates how much revenue Bayer has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Sales per Share

EBIT per share

Earnings per Share

Details

Bayer business model

Bayer AG is a German company that was founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal. The company started out as a manufacturer of dyes, but over time it has evolved into a leading global agrochemical, health, and life science company. Bayer's business model is based on the goal of finding innovative solutions to the societal challenges of the future. This includes promoting agriculture and health, as well as sustainability and the preservation of natural resources. Bayer specializes in three business areas: Pharmaceuticals, Consumer Health, and Crop Science. In the Pharmaceuticals division, Bayer develops and markets innovative drugs for a variety of diseases. The company focuses on research and development in key therapy areas such as cardiology, oncology, hematology, neurology, and immunology. Well-known and successful brands from Bayer in the Pharmaceuticals sector include Xarelto, Kogenate, Stivarga, Eylea, and Nexavar. In the Consumer Health division, Bayer develops and distributes products for consumer health and well-being. This includes self-medication products, dietary supplements, contact lens care products, and animal health products. Well-known brands from Bayer Consumer Health include Aspirin, Bepanthen, Berocca, Coppertone, and Advantage. In the Crop Science division, Bayer develops and markets products and solutions for agriculture. This includes crop protection products, seeds, plant breeding, and digital farming. The goal is to help farmers worldwide operate sustainably and productively to meet the growing demand for food. Well-known brands from Bayer Crop Science include Roundup, Decis, Diflubenzuron, and Dekalb. Bayer is known for its innovative power and has made many inventions and discoveries throughout its history. It was one of the first companies to develop synthetic dyes, and in 1897, it was also the first company in Germany to manufacture Aspirin. Since then, Bayer has made numerous groundbreaking discoveries and is now at the forefront of the pharmaceutical and agrochemical industry. Bayer is headquartered in Leverkusen and operates in over 90 countries worldwide. The company employs over 100,000 people and had a turnover of around 41 billion euros in 2020. The company is also committed to reducing its ecological footprint in line with its business goals and strives to improve sustainability in its value chain. Bayer is one of the most popular companies on Eulerpool.com.

Bayer SWOT Analysis

Helpful

Harmful

Internal

Strengths

Bayer AG has a diverse product portfolio, encompassing pharmaceuticals, consumer healthcare, agricultural products, and animal health. This diversification allows the company to generate revenue from multiple sources and reduces reliance on any single sector.

The company has a strong global presence with operations in more than 90 countries. This allows Bayer to tap into different markets and benefit from localized strategies and customer preferences.

Bayer boasts a strong research and development (R&D) capability, investing significantly in innovation. This enables the company to introduce new and improved products, keeping it competitive in the rapidly evolving healthcare and agricultural industries.

Weaknesses

Bayer has faced several legal challenges related to its products, including lawsuits concerning alleged side effects of certain medications. These legal battles have had a negative impact on the company's reputation and financial performance.

The company heavily relies on the pharmaceutical sector for a significant portion of its revenue. This concentration poses a risk as market dynamics, regulatory changes, or patent expirations can significantly impact financial stability.

Bayer's acquisition of Monsanto, a controversial move due to concerns over genetically modified organisms (GMOs) and the potential environmental impact, has also raised questions about the company's sustainability practices and public perception.

External

Opportunities

Growing demand for healthcare and agricultural products in emerging markets presents an opportunity for Bayer to expand its customer base and revenue streams. This includes addressing the rising healthcare needs of an aging global population.

Advancements in technologies such as precision agriculture, gene editing, and digital health open doors for Bayer to develop innovative solutions, improve productivity, and enhance overall operational efficiency in its various sectors.

Bayer can leverage its established brand and reputation to capitalize on the growing consumer interest in organic and sustainable products. Developing and promoting environmentally friendly solutions can lead to market differentiation and increased market share.

Threats

Intense competition from both established pharmaceutical and agricultural companies, as well as emerging players, poses a threat to Bayer's market position. This includes the potential entry of generic and biosimilar products.

Regulatory requirements and government policies can impact the company's ability to market and sell its products. Changes in regulations related to drug pricing, intellectual property, and environmental safety standards can create challenges for Bayer.

Public scrutiny and consumer activism around controversial products, particularly in the agricultural sector, can harm the company's reputation and result in reduced sales or boycotts.

Bayer Eulerpool Fair Value

Loading chart...

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Bayer historical P/E ratio, EBIT multiple, and P/S ratio

Bayer shares outstanding

The number of shares was Bayer in 2025 — This indicates how many shares 982.42 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Number of stocks

Details

Bayer stock splits

In Bayer's history, there have been no stock splits.

Bayer dividend history and estimates

In 2025, Bayer paid a dividend amounting to 0.11 EUR. Dividend means that Bayer distributes a portion of its profits to its owners.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Dividend

Dividend (Estimate)

Details

Bayer dividend payout ratio

In 2025, Bayer had a payout ratio of 88.97%. The payout ratio indicates the percentage of the company's profits that Bayer distributes as dividends.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Payout ratio

Details

Unfortunately, there are currently no price targets and forecasts available for Bayer.

Bayer Earnings Calls

Bayer Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
5/14/2024	2.88 EUR	14.59 B EUR	2024 Q1
3/5/2024	1.41 EUR	12.26 B EUR	2023 Q4
8/2/2023	2.35 EUR	14.93 B EUR	2023 Q2
5/11/2023	3.69 EUR	0 EUR	2023 Q1
2/28/2023	1.41 EUR	12.29 B EUR	2022 Q4
11/8/2022	1.18 EUR	11.09 B EUR	2022 Q3
8/4/2022	1.91 EUR	12.55 B EUR	2022 Q2
5/10/2022	3.04 EUR	13.96 B EUR	2022 Q1
3/1/2022	1.05 EUR	10.83 B EUR	2021 Q4
11/9/2021	0.89 EUR	9.39 B EUR	2021 Q3
8/5/2021	1.56 EUR	10.45 B EUR	2021 Q2
5/12/2021	2.47 EUR	12.25 B EUR	2021 Q1
2/25/2021	1.29 EUR	10.28 B EUR	2020 Q4
11/3/2020	1 EUR	9.36 B EUR	2020 Q3
8/4/2020	1.56 EUR	10.75 B EUR	2020 Q2
4/27/2020	2.66 EUR	12.24 B EUR	2020 Q1
2/27/2020	1.28 EUR	10.87 B EUR	2019 Q4
10/30/2019	1.2 EUR	9.94 B EUR	2019 Q3
7/26/2019	1.8 EUR	11.87 B EUR	2019 Q2
4/25/2019	2.5 EUR	12.71 B EUR	2019 Q1
2/27/2019	1.68 EUR	10.76 B EUR	2018 Q4
11/13/2018	1.08 EUR	10.37 B EUR	2018 Q3
9/5/2018	1.55 EUR	9.2 B EUR	2018 Q2
5/3/2018	2.07 EUR	9.53 B EUR	2018 Q1
2/28/2018	1.13 EUR	8.92 B EUR	2017 Q4
10/26/2017	1.49 EUR	9.8 B EUR	2017 Q3
7/27/2017	1.77 EUR	12.77 B EUR	2017 Q2
4/27/2017	2.4 EUR	13.05 B EUR	2017 Q1
2/22/2017	1.24 EUR	11.87 B EUR	2016 Q4
10/26/2016	1.65 EUR	11.47 B EUR	2016 Q3
7/27/2016	2.02 EUR	12.31 B EUR	2016 Q2
4/26/2016	2.19 EUR	12.23 B EUR	2016 Q1
2/25/2016	1.27 EUR	11.43 B EUR	2015 Q4
10/29/2015	1.49 EUR	11.41 B EUR	2015 Q3
7/29/2015	1.85 EUR	12.04 B EUR	2015 Q2
4/30/2015	2.16 EUR	12.07 B EUR	2015 Q1
2/26/2015	1.2 EUR	10.84 B EUR	2014 Q4
10/30/2014	1.27 EUR	10.11 B EUR	2014 Q3
7/30/2014	1.59 EUR	10.75 B EUR	2014 Q2
4/28/2014	1.82 EUR	10.66 B EUR	2014 Q1
2/28/2014	1.24 EUR	10.23 B EUR	2013 Q4
10/31/2013	1.23 EUR	9.47 B EUR	2013 Q3
7/31/2013	1.47 EUR	10.59 B EUR	2013 Q2
4/25/2013	1.8 EUR	10.73 B EUR	2013 Q1
2/28/2013	1.08 EUR	9.83 B EUR	2012 Q4
10/30/2012	1.15 EUR	9.43 B EUR	2012 Q3
7/31/2012	1.35 EUR	9.92 B EUR	2012 Q2
4/26/2012	1.48 EUR	9.88 B EUR	2012 Q1
2/28/2012	0.95 EUR	9.26 B EUR	2011 Q4
10/27/2011	1.03 EUR	8.81 B EUR	2011 Q3
7/28/2011	1.32 EUR	9.69 B EUR	2011 Q2
4/28/2011	1.4 EUR	9.22 B EUR	2011 Q1
2/28/2011	0.95 EUR	8.7 B EUR	2010 Q4
10/28/2010	0.94 EUR	8.46 B EUR	2010 Q3
7/29/2010	1.19 EUR	8.76 B EUR	2010 Q2
4/29/2010	1.2 EUR	8.39 B EUR	2010 Q1
2/26/2010	0.86 EUR	7.93 B EUR	2009 Q4
10/27/2009	0.79 EUR	7.63 B EUR	2009 Q3
7/29/2009	0.78 EUR	7.99 B EUR	2009 Q2
4/29/2009	0.96 EUR	8.05 B EUR	2009 Q1
3/3/2009	0.55 EUR	7.89 B EUR	2008 Q4
10/29/2008	0.77 EUR	7.94 B EUR	2008 Q3
7/30/2008	1.06 EUR	8.52 B EUR	2008 Q2
4/24/2008	1.26 EUR	8.7 B EUR	2008 Q1
2/28/2008	0.42 EUR	8.24 B EUR	2007 Q4
11/6/2007	0.47 EUR	7.81 B EUR	2007 Q3
8/7/2007	0.9 EUR	8.36 B EUR	2007 Q2
5/8/2007	0.83 EUR	8.55 B EUR	2007 Q1
3/15/2007	0.28 EUR	8.17 B EUR	2006 Q4
11/27/2006	0.38 EUR	8.01 B EUR	2006 Q3
8/29/2006	0.67 EUR	7.33 B EUR	2006 Q2
4/27/2006	0.9 EUR	7.2 B EUR	2006 Q1
3/6/2006	0.43 EUR	6.88 B EUR	2005 Q4
11/9/2005	0.33 EUR	6.31 B EUR	2005 Q3
8/11/2005	0.62 EUR	0 EUR	2005 Q2
4/29/2005	0 EUR	0 EUR	2005 Q1

...

Eulerpool ESG Scorecard© for the Bayer stock

Eulerpool World ESG Rating (EESG©)

85/ 100

🌱 Environment

👫 Social

🏛️ Governance

Environment

Scope 1 - Direct Emissions	1,880,000
Scope 2 - Indirect emissions from purchased energy	1,650,000
Scope 3 - Indirect emissions within the value chain	8,380,000
Total CO₂ emissions	3,530,000
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees	42.1
Percentage of women in management
Percentage of Asian employees	13
Share of Asian management
Percentage of Hispanic/Latino employees	11
Hispano/Latino Management share
Percentage of Black employees	5
Black Management Share
Percentage of white employees	68
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Bayer shareholders

%	Name	Stocks	Change	Date
7.17652 %	BlackRock Institutional Trust Company, N.A.	70,503,573	4,162,686	7/29/2025
3.46887 %	Temasek Holdings Pte. Ltd.	34,078,853	0	12/31/2024
3.24062 %	The Vanguard Group, Inc.	31,836,511	6,831	7/31/2025
3.00248 %	Silchester International Investors, L.L.P.	29,496,952	0	12/31/2024
2.99392 %	Amundi Asset Management, SAS	29,412,861	1,041,392	5/16/2025
2.93776 %	Norges Bank Investment Management (NBIM)	28,861,165	0	12/31/2024
2.89842 %	MFS Investment Management	28,474,699	0	12/31/2024
2.87385 %	Dodge & Cox	28,233,293	2,523,717	2/13/2025
1.96213 %	Harris Associates L.P.	19,276,358	-9,897,566	6/30/2025
1.14187 %	BlackRock Advisors (UK) Limited	11,217,982	288,611	7/31/2025
0.94291 %	Geode Capital Management, L.L.C.	9,263,374	130,925	6/30/2025
0.89969 %	BlackRock Asset Management Deutschland AG	8,838,775	-140,847	7/31/2025
0.88304 %	Dimensional Fund Advisors, L.P.	8,675,177	251,866	7/31/2025
0.84147 %	DWS Investment GmbH	8,266,800	141,758	7/31/2025
0.70697 %	Fidelity Institutional Asset Management	6,945,418	-31,236	3/31/2025
0.57295 %	Charles Schwab Investment Management, Inc.	5,628,797	16,889	7/31/2025
0.56190 %	Fidelity Management & Research Company LLC	5,520,256	79,028	6/30/2025
0.55673 %	Capital World Investors	5,469,429	11,902	7/31/2025
0.37846 %	Goldman Sachs Asset Management, L.P.	3,718,034	72,617	6/20/2025
0.33662 %	Fidelity Investments Canada ULC	3,307,071	179,197	3/31/2025
0.31579 %	BlackRock Investment Management (UK) Ltd.	3,102,432	3,891	6/30/2025
0.31164 %	State Street Global Advisors (US)	3,061,619	11,274	7/31/2025
0.30911 %	Arga Investment Management, LP	3,036,743	-74,666	6/30/2025
0.27794 %	Schroder Investment Management Ltd. (SIM)	2,730,523	-13,360	6/30/2025
0.26890 %	Lazard Asset Management, L.L.C.	2,641,687	-80,719	7/31/2025
0.25162 %	JPMorgan Asset Management U.K. Limited	2,471,947	1,685,371	6/30/2025
0.24470 %	CPP Investment Board	2,404,000	629,000	3/31/2024
0.24016 %	Deka Investment GmbH	2,359,345	25,228	7/31/2025
0.23951 %	California State Teachers Retirement System	2,352,987	569,552	6/30/2024
0.23883 %	State Street Global Advisors (UK) Ltd.	2,346,346	15,641	7/31/2025
0.23758 %	Fidelity International	2,333,989	395,387	6/30/2025
0.22178 %	Cobas Asset Management, SGIIC, SA	2,178,837	-26,518	6/30/2025
0.21007 %	Ruffer LLP	2,063,785	-65,160	6/30/2025
0.20572 %	Baillie Gifford & Co.	2,021,064	-1,502	3/31/2025
0.20471 %	Aviva Investors Global Services Limited	2,011,094	-6,324	6/30/2025
0.19683 %	Macquarie Investment Management	1,933,650	0	5/31/2024
0.17655 %	California Public Employees' Retirement System	1,734,507	-71,038	6/30/2024
0.17645 %	HSBC Global Asset Management (UK) Limited	1,733,475	41,609	6/30/2025
0.17411 %	JP Morgan Asset Management	1,710,477	43,756	7/31/2025
0.16422 %	Nuveen LLC	1,613,304	0	6/30/2025
0.15049 %	Jupiter Asset Management Ltd.	1,478,424	1,478,424	6/30/2025
0.14601 %	Van Eck Associates Corporation	1,434,408	-21	7/31/2025
0.14486 %	UBS Asset Management (UK) Ltd.	1,423,165	25,339	7/31/2025
0.14169 %	CapitalatWork - Foyer Group	1,392,017	0	6/30/2025
0.13407 %	Legal & General Investment Management Ltd.	1,317,109	878	7/31/2025
0.12087 %	Dimensional Fund Advisors, Ltd.	1,187,404	32,000	6/30/2025
0.10702 %	DWS Investments UK Limited	1,051,419	16,663	7/31/2025
0.10573 %	Putnam Investment Management, L.L.C.	1,038,725	477,050	6/30/2025
0.09832 %	azValor Asset Management SGIIC, SAU	965,960	965,960	12/31/2024
0.09478 %	Vanguard Global Advisers LLC	931,161	8,030	6/30/2025
0.09472 %	Union Investment Privatfonds GmbH	930,518	0	9/30/2024
0.09087 %	BNP Paribas Asset Management Europe SAS	892,709	130,106	6/30/2025
0.08934 %	MEAG Munich ERGO Kapitalanlagegesellschaft mbH	877,734	710,444	3/31/2025
0.08803 %	DIVAS Asset Management AG	864,841	-25,626	6/30/2025
0.08491 %	Northern Trust Investments, Inc.	834,169	603	7/31/2025
0.08302 %	AQR Capital Management, LLC	815,564	334,376	6/30/2025
0.07936 %	Northern Trust Global Investments Limited	779,605	132,216	6/30/2025
0.07613 %	BlackRock Financial Management, Inc.	747,887	5,932	2/28/2025
0.07527 %	M&G Investment Management Ltd.	739,459	542,174	4/30/2025
0.07505 %	Franklin Advisers, Inc.	737,263	275,362	6/30/2025
0.06983 %	BNP Paribas Asset Management UK Limited	686,070	24,323	6/30/2025
0.06804 %	1832 Asset Management L.P.	668,427	584,420	12/31/2024
0.06734 %	Pacer Advisors, Inc.	661,610	-203,971	6/30/2025
0.06728 %	UBS Fund Management (Switzerland) AG	660,971	11,641	7/31/2025
0.06722 %	Vanguard Investments Australia Ltd.	660,427	-1,835	6/30/2025
0.06610 %	BlackRock Asset Management Canada Limited	649,399	0	7/31/2025
0.06260 %	Pzena Investment Management, LLC	615,028	-97,194	6/30/2025
0.05766 %	Handelsbanken Kapitalförvaltning AB	566,472	20,347	6/30/2025
0.05443 %	Zürcher Kantonalbank (Asset Management)	534,692	6,869	7/31/2025
0.05289 %	American Century Investment Management, Inc.	519,647	43,497	7/31/2025
0.05012 %	DBX Advisors LLC.	492,426	0	7/31/2025
0.04828 %	Oddo BHF Asset Management GmbH	474,345	6,200	6/30/2025
0.04526 %	Niche Asset Management Limited	444,600	0	5/31/2025
0.04426 %	Invesco Capital Management LLC	434,825	-173	7/31/2025
0.04337 %	BWM AG	426,100	0	6/30/2025
0.04258 %	Seligson & Co Rahastoyhtiö Oyj	418,341	-734	5/31/2025
0.04129 %	Assenagon Asset Management S.A.	405,604	1,691	7/31/2025
0.03982 %	Eurizon Capital SGR S.p.A.	391,220	117,321	6/30/2025
0.03965 %	Mediolanum International Funds Limited	389,550	57,833	3/31/2025
0.03870 %	Lansförsäkringar Fondförvaltning AB	380,201	4,961	6/30/2025
0.03827 %	Ilmarinen Mutual Pension Insurance Company	376,004	166,816	12/31/2024
0.03576 %	Bank Julius Bär & Co. AG	351,348	0	6/30/2025
0.03558 %	UBS Asset Management (Switzerland)	349,561	-2,796	7/31/2025
0.03516 %	UBS Asset Management Switzerland AG	345,454	0	6/30/2025
0.03471 %	BMO Asset Management Inc.	340,966	-31,500	7/31/2025
0.03363 %	TD Asset Management Inc.	330,346	2,914	6/30/2025
0.03298 %	Rothschild & Co Asset Management Europe SCS	323,982	323,982	6/30/2025
0.03244 %	AllianceBernstein L.P.	318,699	-6,637	6/30/2025
0.03216 %	Link Fund Solutions, Ltd.	315,930	0	6/30/2024
0.03024 %	Manulife Investment Management (North America) Limited	297,104	0	6/30/2025
0.02921 %	TOP Vermögensverwaltung AG	287,000	0	6/30/2025
0.02868 %	Pictet Asset Management Ltd.	281,767	16,229	4/30/2025
0.02859 %	T. Rowe Price Associates, Inc.	280,888	29,832	6/30/2025
0.02834 %	PIMCO (US)	278,413	0	6/30/2025
0.02785 %	Anima SGR S.p.A.	273,652	-449	1/31/2025
0.02702 %	BlackRock Investment Management, LLC	265,405	-1,481	6/30/2025
0.02466 %	Epsilon SGR SpA	242,226	0	6/30/2025
0.02403 %	Neuberger Berman, LLC	236,030	196	6/30/2025
0.02401 %	SK Vermögensverwaltung GmbH	235,900	10,000	6/30/2025
0.02347 %	FPS Vermögensverwaltung GmbH	230,600	0	12/31/2023

...

Bayer Executives and Management Board

Mr. William Anderson

(57)

Bayer Chairman of the Management Board, Chief Executive Officer

Compensation 8.84 M EUR

Mr. Rodrigo Santos

(50)

Bayer Member of the Management Board, Head of the Crop Science

Compensation 3.77 M EUR

Mr. Stefan Oelrich

(55)

Bayer Member of the Management Board, Head of the Pharmaceuticals Division

Compensation 3.68 M EUR

Mr. Wolfgang Nickl

(54)

Bayer Chief Financial Officer, Member of the Management Board

Compensation 3.63 M EUR

Mr. Julio Triana

(59)

Bayer Member of the Management Board, Head of the Consumer Health Division

Compensation 3.33 M EUR

...

Bayer Supply Chain

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Farmacias Benavides B	SupplierCustomer		0,69
Blackhawk Network Holdings, Inc.	SupplierCustomer			-0,13	-0,01	-0,03	0,07
SICIT Group SpA	SupplierCustomer					-0,06	-0,13
Vincerx Pharma	SupplierCustomer	0,93	0,94	-0,84	-0,89	-0,74
Insignia Systems	SupplierCustomer	0,89	0,92	-0,10	-0,68	-0,26	-0,28
Burning Rock Biotech ADR	SupplierCustomer	0,89	0,90	-0,65	-0,77	-0,41	-0,08
Smartspace Software	SupplierCustomer	0,88	0,79	-0,49	-0,26	-0,27	-0,37
BASF	SupplierCustomer	0,88	0,85	-0,57	-0,59	-0,62	-0,34
ImmunoGen	SupplierCustomer	0,88	0,86	-0,23	-0,73	-0,63	-0,38
Johnson & Johnson	SupplierCustomer	0,87	0,30	0,88	0,83	0,65	0,07

...

Most common questions regarding Bayer

The business model of Bayer AG is focused on the development, manufacturing, and sale of healthcare and agricultural products. As a global pharmaceutical and life sciences company, Bayer AG operates in various sectors such as Pharmaceuticals, Consumer Health, Crop Science, and Animal Health. With its innovative research and development, Bayer AG aims to improve people's lives through its products and solutions. By maintaining a diverse portfolio, strong market presence, and strategic partnerships, the company seeks to address global challenges and contribute to a sustainable future in the fields of healthcare and agriculture.

The Bayer AG is a German company that operates in various business sectors. The company is active in the chemical and pharmaceutical industry and offers a wide range of products and services. Pharma and Health One of Bayer's most well-known business sectors is pharma and health. The company produces a variety of medications used for treating diseases such as diabetes, cancer, cardiovascular diseases, and many more. The most well-known medications include the pain reliever Aspirin, the contraceptive Yaz, and the cancer medication Nexavar. Crop Science Another important business sector of Bayer is Crop Science. Bayer produces seeds and plant protection products for the agribusiness sector. The company offers a wide range of products for the cultivation of crops such as grains, vegetables, and fruits. The company also supports farmers in the efficient use of water and energy for sustainable agriculture. Bayer Crop Science is a key player in the global agricultural landscape. Consumer Health Bayer also has a Consumer Health business sector that offers a variety of products for health and personal care. The company produces medications for minor illnesses and diseases such as cold and flu, as well as self-care products such as pain ointments, antiseptics, skin creams, and vitamins. The most well-known products include Coppertone sunscreen and the pain reliever Aleve. Animal Health Bayer also utilizes its expertise in animal health by producing medications and services. This business sector focuses on the health and well-being of livestock and pets. The company has an extensive range of products for the treatment and prevention of disease-related risks in pets as well as livestock. Bayer also has various business sectors focusing on the production of chemicals, materials, and technologies for the production of plastics, paints, adhesives, high-tech products, and more. Overall, Bayer AG's business model is oriented towards strong diversification to minimize risks and seize opportunities in various markets. With a wide range of products and a strong presence in different regions, Bayer continuously generates a high volume of revenue through its strong research and development and is an important company for the German economy.

Sector

Health

Industry

Pharmaceuticals

Number of shares

982,420,000

Employees

99,841

Revenue growth Ø5 years

2.4 %

EBIT growth Ø5 years

—

Net Income growth Ø5 years

-24.63 %

Website bayer.de

Country

🇩🇪

Currency

EUR

Initial public offering

Nov 28, 1997

ISIN

DE000BAY0017

Cusip

D0712D163

Sedol

5069211

Market capitalization

45.18 B EUR

Bayer Directors Dealings

Quality Investing

Details

1 / 10

PEG

-3.58

P/E ratio

-17.5

Forward P/E ratio 2025

9.48

Forward P/E ratio 2026

9.3

Forward P/E ratio 2027

8.54

Forward P/E ratio 2028

7.7

Forward P/E ratio 2029

7.28

P/S ratio

0.96

Forward P/S ratio

0.96

ROE (Return on Equity)

-8 %

ROA (Return on Assets)

-2.3 %

ROCE (Return on Capital Employed)

4.88 %

ROIC (Return on Invested Capital)

-6.22 %

Dividend

0.11 EUR

Dividend yield

0.24 %

Dividend growth Ø5Y

-44.01 %

Dividend payments per year

Dividend paid since

21 years

Dividend not reduced since

2 years

Dividend increased since

0 years

Dividend withholding tax

26.38 %

Bayer Peer Group

MPH Health Care AG

Merck KGaA

Dermapharm Holding SE

PharmaSGP Holding SE

Bayer Eulerpool News

Eulerpool News August 7 · Business · 7. August 2025

Bayer cuts over 11,000 jobs – Management announces further cuts by 2026

Eulerpool News May 14 · · 14. Mai 2025

Bayer surprises with robust quarter – Pharmaceutical business defies agricultural downturn

Eulerpool News March 25 · Pharma · 25. März 2025

$2.1 Billion Verdict Against Bayer Intensifies Glyphosate Crisis in the USA

Eulerpool News March 16 · Business · 16. März 2025

Bayer achieves first success in glyphosate lobbying in the USA – Nationwide strategy in preparation

Eulerpool News March 8 · Pharma · 8. März 2025

Bayer expects the most difficult year in 2025 - Hope for recovery starting in 2026

Eulerpool News March 5 · Pharma · 5. März 2025

Bayer Under Pressure – Anderson's Reform Course Decides the Future of the Company

Eulerpool News January 16 · Business · 16. Januar 2025

Bayer Ordered to Pay 100 Million Dollars in Damages for PCB Contamination in US School

Eulerpool News January 14 · Business · 14. Januar 2025

Bayer advances cell therapy against Parkinson's

Bayer Earnings Calls

No Earnings Calls available for Bayer

Bayer News

All Bayer News

Bayer Ticker

Stock Exchange	Bayer Ticker
BERLIN	BAYN.BE
DÜSSELDORF	BAYN.DU
FRANKFURT	BAYN.F
HAMBURG	BAYN.HM
LONDON	0P6S.L
MILAN	1BAYN.MI
MUNICH	BAYN.MU
NASDAQ	BAYZF
SIX	BAYN.SW
STUTTGART	BAYN.SG
VIENNA	BAYN.VI
WARSAW	BAY.WA
WSE	BAY.WA
XETRA	BAYN.DE

Bayer FIGI

Bayer Ticker	Bayer FIGI
BAYN:GR	BBG000BBWDG1
BAYN:GF	BBG000BBWDT7
BAYN:GD	BBG000BBWF12
BAYN:GY	BBG000BBWF85
BAYN:GS	BBG000BBWG29
BAYN:GM	BBG000BBWH90
BAYN:GB	BBG000BBWJ50
BAYN:GI	BBG000BBWK02
BAYN:GH	BBG000BBWKS2
BAYN:SW	BBG000BBWS96
BAYN:SE	BBG000BBWT49
BAYZF:US	BBG000BX8VK5
BAYZF:PQ	BBG000BX91W7
BAYZF:UV	BBG000BX92S0
BAYND:IX	BBG000DHR6B2
BAYCHF:EU	BBG000GDBC68
BAYCHF:EO	BBG000GDBCS4
BAYCHF:E1	BBG000GDCV38
BAYCHF:XT	BBG000GDCVR2
BAYCHF:XW	BBG000GDCWR0
1BAYN:IM	BBG000GWH1F4
BAY:IC	BBG000GWH2K6
1BAYN:IF	BBG000GWJ509
BAY:EO	BBG000J6SMS6
BAY:XH	BBG000J6SQ25
BAY:XC	BBG000J6SQQ9
BAY:XF	BBG000J6SR87
BAY:XE	BBG000J6SS94
BAY:XJ	BBG000J6SSM9
BAY:XL	BBG000J6STJ1
BAY:XG	BBG000J6SVX0
BAY:XO	BBG000J6SW77
BAY:XS	BBG000J6V0V6
BAY:XA	BBG000J6V2L3
BAY:E1	BBG000J6V3L1
BAY:XT	BBG000J6V3V0
BAY:XW	BBG000J6V4C9
BAY:EU	BBG000J6V5S9
BAYGBX:EU	BBG000JK55G0
BAYGBX:EO	BBG000JK55S7
BAYGBX:XH	BBG000JK57M9
BAYGBX:XC	BBG000JK58J1
BAYGBX:XF	BBG000JK59K7
BAYGBX:XE	BBG000JK5CK0
BAYGBX:XJ	BBG000JK5DC7
BAYGBX:XL	BBG000JK5DZ2
BAYGBX:XG	BBG000JK5G85
BAYGBX:XO	BBG000JK5H56
BAYGBX:XS	BBG000JK5L57
BAYGBX:XA	BBG000JK5LF6
BAYGBX:E1	BBG000JK5MJ0
BAYGBX:XT	BBG000JK5N71
BAYGBX:XW	BBG000JK5NP1
BAYGBP:EO	BBG000JLW0L3
BAYGBP:XH	BBG000JLW319
BAYGBP:XC	BBG000JLW3G3
BAYGBP:XE	BBG000JLW4C5
BAYGBP:XJ	BBG000JLW4K6
BAYGBP:XG	BBG000JLW6D9
BAYGBP:XO	BBG000JLW6L0
BAYGBP:XA	BBG000JLW8Y2
BAYGBP:E1	BBG000JLW9D3
BAYGBP:XT	BBG000JLW9Q9
BAYGBP:XW	BBG000JLXD43
BAYUSD:EU	BBG000K1MJ17
BAYUSD:EO	BBG000K1MJS8
BAYUSD:E1	BBG000K1MXZ9
BAYUSD:XT	BBG000K1NZN6
BAYUSD:XW	BBG000K1Q265
BAYAUD:EO	BBG000L4NFC5
BAYAUD:E1	BBG000L4PXS7
BAYAUD:XT	BBG000L4PYB3
BAYAUD:XW	BBG000L4PZ48
BAYAUD:EU	BBG000L4PZN7
BAYNOK:EO	BBG000N2L6B0
BAYNOK:E1	BBG000N2MJ12
BAYNOK:XT	BBG000N2MJ76
BAYNOK:XW	BBG000N2MJP6
BAYNOK:EU	BBG000N2ML17
BAYND:TQ	BBG000N3MSS1
BAYND:BQ	BBG000NZNYK4
BAYND:EB	BBG000NZXJ62
4BAYN:TE	BBG000R8K526
BAYCAD:EO	BBG000RNX1Z2
BAYCAD:E1	BBG000RNX7H9
BAYCAD:XT	BBG000RNX8M1
BAYCAD:XW	BBG000RNX8R6
BAYCAD:EU	BBG000RNX9S3
BAYN:TH	BBG000TJ1L08
BAYEGP:EO	BBG001HTWWQ1
BAYEGP:XE	BBG001HTWWY2
BAYEGP:E1	BBG001HTWX89
BAYEGP:XT	BBG001HTWX98
BAYEGP:XW	BBG001HTWXB5
BAYEGP:EU	BBG001HTWXD3
BAYND:S1	BBG001MBWCD2
BAYER:HB	BBG002F046D6
0P6S:LO	BBG0039C2QH9
BAYCHF:XV	BBG00591BYV5
BAY:XV	BBG00591KM69
BAYGBX:XV	BBG00591MGM2
BAYGBP:XV	BBG00591MPC3
BAYAUD:XV	BBG00591R0X0
BAYNOK:XV	BBG00591SBP4
BAYCAD:XV	BBG00591X170
BAYEGP:XV	BBG00591Z597
BAYND:QX	BBG005HKZND2
BAYNN:MM	BBG005PTPF88
BAYNN:MF	BBG005PTPF97
BAYRUB:EO	BBG0066JDZG9
BAYRUB:XH	BBG0066JDZK4
BAYRUB:XF	BBG0066JDZM2
BAYRUB:XE	BBG0066JDZP9
BAYRUB:XJ	BBG0066JDZQ8
BAYRUB:XL	BBG0066JDZR7
BAYRUB:XG	BBG0066JDZS6
BAYRUB:XO	BBG0066JDZT5
BAYRUB:XS	BBG0066JDZY9
BAYRUB:XA	BBG0066JDZZ8
BAYRUB:E1	BBG0066JF001
BAYRUB:XT	BBG0066JF010
BAYRUB:XW	BBG0066JF029
BAYRUB:XU	BBG0066JF038
BAYRUB:XV	BBG0066JF056
BAYRUB:EU	BBG0066JF0W6
BAYN:BW	BBG006M6Y3H6
BAYPLN:EO	BBG006N9MLX4
BAYPLN:XH	BBG006N9MM08
BAYPLN:XF	BBG006N9MM26
BAYPLN:XE	BBG006N9MM44
BAYPLN:XJ	BBG006N9MM53
BAYPLN:XL	BBG006N9MM62
BAYPLN:XG	BBG006N9MM71
BAYPLN:XO	BBG006N9MM80
BAYPLN:XS	BBG006N9MMD4
BAYPLN:XA	BBG006N9MMF2
BAYPLN:E1	BBG006N9MMG1
BAYPLN:XT	BBG006N9MMH0
BAYPLN:XW	BBG006N9MMJ8
BAYPLN:XU	BBG006N9MMK6
BAYPLN:XV	BBG006N9MMM4
BAYPLN:EU	BBG006N9MMT7
BAYND:B3	BBG006T6K2G7
BAYND:L3	BBG006T9VBW1
BAYN:QT	BBG0077H5593
BAYND:PO	BBG008GZCHY9
BAYNEUR:SW	BBG008P7G3S5
BAYNEUR:SE	BBG008P7G3V1
BAYE:B3	BBG00CX7Z1J0
BAYE:PO	BBG00CX81CV7
BAYE:L3	BBG00CX88WD6
BAYN:GZ	BBG00FGWTXC1
BAYN:RO	BBG00GWY7PX5
BAYN:RE	BBG00GWY7PY4
BAYNZ:PO	BBG00GXZSPL1
BAYNZ:L3	BBG00GXZSRK8
BAYNZ:B3	BBG00GXZSSD4
BAYNZ:EB	BBG00GY0DGG9
BAYNZ:IX	BBG00GY0DGW1
BAYN:AV	BBG00GY18HF2
BAY:XM	BBG00J9VPKC5
BAYCHF:XX	BBG00JN78LR3
BAY:XX	BBG00JN7H801
BAYGBX:XX	BBG00JN7K3S8
BAYGBP:XX	BBG00JN7KBJ0
BAYUSD:XX	BBG00JN7LCK5
BAYAUD:XX	BBG00JN7NNY4
BAYNOK:XX	BBG00JN7PZR3
BAYCAD:XX	BBG00JN7TNR6
BAYEGP:XX	BBG00JN7WTB6
BAYRUB:XX	BBG00JN869R0
BAYPLN:XX	BBG00JN871Y8
BAYNN:MU	BBG00JX0PB36
BAYHUF:EO	BBG00KDNYFP2
BAYHUF:XH	BBG00KDNYFS9
BAYHUF:XF	BBG00KDNYFV5
BAYHUF:XE	BBG00KDNYFX3
BAYHUF:XJ	BBG00KDNYFY2
BAYHUF:XL	BBG00KDNYFZ1
BAYHUF:XG	BBG00KDNYG07
BAYHUF:XO	BBG00KDNYG16
BAYHUF:XS	BBG00KDNYG52
BAYHUF:XA	BBG00KDNYG61
BAYHUF:E1	BBG00KDNYG70
BAYHUF:XT	BBG00KDNYG89
BAYHUF:XW	BBG00KDNYG98
BAYHUF:XU	BBG00KDNYGB5
BAYHUF:XV	BBG00KDNYGC4
BAYHUF:XM	BBG00KDNYGD3
BAYHUF:XQ	BBG00KDNYGG0
BAYHUF:XX	BBG00KDNYGH9
BAYHUF:XZ	BBG00KDNYGJ7
BAYHUF:EU	BBG00KDNYGL4
BAYNEUR:T2	BBG00MZYZRL7
BAYND:QE	BBG00NL2M9Y0
BAYND:T1	BBG00NLK3LK9
BAYND:I2	BBG00NQB52K4
BAYNEUR:WT	BBG00NR8NZQ1
BAYRON:XS	BBG00PPZ6MM0
BAYRON:XH	BBG00PPZ6MQ6
BAYRON:XF	BBG00PPZ6MS4
BAYRON:XD	BBG00PPZ6MT3
BAYRON:XE	BBG00PPZ6MV0
BAYRON:XJ	BBG00PPZ6MW9
BAYRON:XL	BBG00PPZ6MX8
BAYRON:XG	BBG00PPZ6MY7
BAYRON:XO	BBG00PPZ6MZ6
BAYRON:XN	BBG00PPZ6N02
BAYRON:XA	BBG00PPZ6N39
BAYRON:XT	BBG00PPZ6N57
BAYRON:XW	BBG00PPZ6N66
BAYRON:XU	BBG00PPZ6N75
BAYRON:XV	BBG00PPZ6N84
BAYRON:XM	BBG00PPZ6N93
BAYRON:EU	BBG00PPZ6NG5
BAYERT:PO	BBG00XTVRQJ0
BAYERT:L3	BBG00XTVRRV4
BAYERT:B3	BBG00XTVRS33
BAYERT:L1	BBG00Y7BFVT7
BAYND:L1	BBG00Y7BFW06
BAYNZ:L1	BBG00Y7BFW51
BAYND:S4	BBG00YJ84L06
BAYN:LA	BBG018H7GL85
BAYN:LU	BBG018J13NR5
BAY:PW	BBG01H6YCKZ4

All fundamentals about Bayer

Our stock analysis for Bayer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bayer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

The Modern Financial Terminal

Trusted by leading companies and financial institutions

Bayer Stock BAYN.DE

Price

Price

TickerBAYN.DE

ISINDE000BAY0017

Bayer stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Bayer Revenue, EBIT, Net Income

Bayer Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Bayer stock margins

Bayer Stock Sales Revenue, EBIT, Earnings per Share

Bayer business model

Bayer SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Bayer Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Bayer historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Bayer shares outstanding

Bayer stock splits

Bayer dividend history and estimates

Bayer dividend payout ratio

The World’s Best Investors Are On Eulerpool

Bayer Earnings Calls

Bayer Earnings Estimates

Eulerpool ESG Scorecard© for the Bayer stock

Eulerpool World ESG Rating (EESG©)

85/ 100

🌱 Environment

👫 Social

🏛️ Governance

Environment

Social

Governance (Corporate Governance)

Bayer shareholders

Bayer Executives and Management Board

Mr. William Anderson

Mr. Rodrigo Santos

Mr. Stefan Oelrich

Mr. Wolfgang Nickl

Mr. Julio Triana

Bayer Supply Chain

Most common questions regarding Bayer

What is the business model of Bayer?

In which industries is Bayer primarily active?

Who are the main competitors of Bayer in the market?

What is the history and background of the company Bayer?

What significant milestones has the company Bayer achieved?

In which countries and regions is Bayer primarily present?

Ticker
BAYN.DE

ISIN
DE000BAY0017